Search Result "miR-1-3p"
miR-1-3p/CELSR3 Participates in Regulating Malignant Phenotypes of Lung Adenocarcinoma Cells
Journal: Current Gene Therapy
Volume: 21 Issue: 4 Year: 2021 Page: 304-312
Author(s): Huiwen Miao,Qingxin Zeng,Shaohua Xu,Zhoumiao Chen
miR-18a-3p Encourages Apoptosis of Chondrocyte in Osteoarthritis via HOXA1 Pathway
Journal: Current Molecular Pharmacology
Volume: 13 Issue: 4 Year: 2020 Page: 328-341
Author(s): Baiyang Ding,Shujuan Xu,Xiumin Sun,Jianming Gao,Wenlei Nie,Hongguang Xu
MiR-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 0 Year: 2020 Page: 1-9
Author(s): Mohamed A. Ragheb,Marwa H. Soliman,Emad M. Elzayat,Mervat S. Mohamed,Nada El-Ekiaby,Ahmed I. Abdelaziz,Abdelhady A. Abdelwahab
miR-490-3p Alleviates Cardiomyocyte Injury via Targeting FOXO1
Journal: Protein & Peptide Letters
Volume: 29 Issue: 11 Year: 2022 Page: 917-924
Author(s):
Regulatory Mechanism miR-302a-3p/E2F1/SNHG3 Axis in Nerve RepairPost Cerebral Ischemic Stroke
Journal: Current Neurovascular Research
Volume: 18 Issue: 5 Year: 2021 Page: 515-524
Author(s): Tianpeng Jiang,Shi Zhou,Xueqing Huang,Lizhou Wang,Xiaoyu Sun
miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression
Journal: Current Molecular Medicine
Volume: 18 Issue: 3 Year: 2018 Page: 135-141
Author(s): Y. Fu,L.-Q. Sun,Y. Huang,J. Quan,X. Hu,D. Tang,R. Kang,N. Li,X.-G. Fan
MiR‐372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 0 Year: 2020 Page: 1-11
Author(s): Marwa H. Soliman,Mohamed A. Ragheb,Emad M. Elzayat,Mervat S. Mohamed,Nada El-Ekiaby,Ahmed I. Abdelaziz,Abdelhady A. Abdelwahab
miR-141-3p Enhanced Radiosensitivity of CRC Cells
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 27 Issue: 1 Year: 2024 Page: 118-126
Author(s):
HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation,Migration, and Invasion in Triple-negative Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 5 Year: 2023 Page: 363-378
Author(s):
Neuropilin-2 Inhibits Drug Resistance and Progression of MelanomaInvolving the MiR-331-3p Regulated Cascade
Journal: Current Molecular Pharmacology
Volume: 16 Issue: 7 Year: 2023 Page: 787-799
Author(s):